pone.0296197.g002.tif (148.38 kB)
Framework for evaluation of the feasibility of implementing the advanced HIV disease care package.
figure
posted on 2023-12-22, 18:29 authored by Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van HeerdenPillars of the evaluation assessed with quantitative methods are shown in yellow, with mixed methods in green. Specific topics of interest for feasibility evaluation are shown in blue. AlereLAM, Alere tuberculosis lipoarabinomannan lateral flow assay. Immy CrAg, cryptococcal antigen lateral flow assay; VISITECT CD4, Omega VISITECT CD4 Advanced Disease.
History
Usage metrics
Categories
Keywords
thematic content analysislong procedural duration2021 &# 8211200cells /&# 956cd4 &# 880473 minutes ).advanced hiv diseaseamong 276 plhivcare cd4 testingtuberculosis case findingoffered hiv testingamong 676 plhivpositive tuberculosis testcase findingcd4 testingamong plhivsputum ).care packagetest resultssemiquantitative testhiv statusoffered visitecttuberculosis symptomstuberculosis statustuberculosis diagnosisalere tuberculosisxlink ">venous bloodunknown statustreatment statusstudy staffrecruited nearprocess compliancepeople livingnewly diagnosedmgit culturelow specificitylogistic regressionlikely explainedintervention deliveryimmy craggroup discussionsearly effectiveness328 without
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC